Quick Takeaways
- Karpus Management, Inc. filed SCHEDULE 13G/A for Drugs Made In America Acquisition Corp. Common (DMAA).
- Disclosed ownership: 8.2%.
- Date of event: 30 Jun 2025.
Karpus Management, Inc. - 30 Jun 2025 SCHEDULE 13G/A Report for Drugs Made In America Acquisition Corp. Common (DMAA)
- Filing Manager
- Karpus Management, Inc.
- Reporting Manager
- KARPUS MANAGEMENT, INC.
- Symbol
- DMAA
- Shares outstanding
- 33,505,604 shares
- Disclosed Ownership
- 2,744,109 shares
- Ownership
- 8.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 16:05:18 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 14 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Karpus Management, Inc. disclosed 8.2% ownership in Drugs Made In America Acquisition Corp. Common (DMAA) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 14 May 2025.
- Current filing was accepted on 14 Aug 2025, 16:05.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| KARPUS MANAGEMENT, INC. | 8.2% | 2,744,109 | 2,744,109 | 0 | /s/ Jodi L. Hedberg | Jodi L. Hedberg / Chief Compliance Officer |